Do you have any info on where Caldwell's contract stands compared to other small like companies? I know another small biotech I own ($150M cap) pays our CEO slightly less salary. With regard to bonus shares, 7% of the company's value seems a bit steep. this company just allocated approx 6% (3M shares) for the entire management team to be vested over 2-3 years (also they were options to be based at the current share price and not just given to them at a $0 base).
Seems a bit rich to me. It does say the company will ask the Board to approve it> Who is the company (Caldwell?)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.